Positive Results From Roche Phase III Trials Into Etrolizumab
Roche Holding AG (RO.EB) said Tuesday that new data from two ongoing phase-III trials evaluating etrolizumab in patients with inflammatory bowel disease, or IBD, indicated that patients showed an improvement.
via FOX BUSINESS NEWS
http://ift.tt/2z0QAv8
No comments:
Post a Comment